Navigation Links
Biomoda Hires Manzano Strategies LLC to Spearhead Government Affairs Efforts
Date:10/31/2007

ALBUQUERQUE, N.M., Oct. 31 /PRNewswire-FirstCall/ -- Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://www.biomoda.com) of Albuquerque, NM, maker of early lung cancer detection testing and other cancer diagnostic technology, announced today it hired Manzano Strategies LLC, a government consulting firm focused on building government partnerships with companies interested in defense appropriations and development of advanced technologies.

Manzano Strategies' (http://www.manzanostrategies.com) partners David Montoya and Bruce Donisthorpe will spearhead efforts with the New Mexico legislature and federal government in promoting programs using Biomoda's early lung cancer detection technology based on a patented porphyrin application that preferentially binds to cancerous or aberrant cells extracted from lung sputum samples. Cancerous cells glow red under fluorescent light to allow detection under a microscope.

Before launching Manzano Strategies, Montoya served as Chief of Staff of Los Alamos National Laboratory's Nuclear Weapons Program. He served as a senior policy advisor to Senator Jeff Bingaman, responsible for defense, veterans' affairs, economic development and other programs. Donisthorpe was Legislative Director for Representative Joe Skeen and an Associate Staff Member of the US House Appropriations Committee prior to entering private business as a government affairs advisor for New Mexico Institute of Mining and Technology (New Mexico Tech), among other high-technology and defense- related clients.

"David and Bruce represent two of the best advisors in the country related to our work with the government in securing support for programs that will help our veterans and the military in the field of health care," said John Cousins, President of Biomoda. "We look forward to using every bit of their expertise in promoting Biomoda on a national scale."

Biomoda's, the patented technology, a non-invasive cytology based assay, is designed for cancer screening of large populations at a reasonable cost. Current diagnostic methods for lung cancer, including CT scans and X-rays, often detect the disease only at more advanced stages and are relatively expensive.

Lung cancer claims more lives than any other cancer. The expected 5-year survival rate for all patients combined in whom lung cancer is diagnosed is 15 percent and by contrast, the 5-year survival rate for cases detected when the disease is still localized is 50 percent. At the present time, only 16 percent of lung cancer cases are diagnosed at this early stage.

Contact: John Cousins (505) 821-0875


'/>"/>
SOURCE Biomoda, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. Merge Healthcare hires new VP of finance
3. PDS hires new VP, buys former health club building
4. Strategies to Identify and Confirm Phase I Metabolites of Glyburide Using the 4000 Q TRAP System
5. Going for the "Big Score" or hedging your bets: Two economic development strategies
6. Innovative Health Strategies near Milwaukee set to profit from Medicare expansion
7. Entrepreneurs Conference to focus on strategies, tools and culture
8. Sales Strategies for the High-Tech Entrepreneur
9. Spend Money to Make Money and Dump Obsolete Tech Strategies
10. Institute Helps Industries Enhance Business Strategies
11. GameBased Learning Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Alex,s Lemonade Stand Foundation (ALSF), a ... will open a state-of-the-art bioinformatics lab, using ,big data, ... announcement comes as Liz Scott , co-executive director ... Moonshot Summit in Washington, D.C. , ... participant and advocate of pediatric cancer research and awareness. ...
(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: ... been advised by its major shareholders, Clean Technology Fund ... United States based venture capital funds ... of Biorem (on a fully diluted, as converted basis), ... disposition of their entire equity holdings in Biorem to ...
(Date:6/27/2016)...  Sequenom, Inc. (NASDAQ: SQNM ), a ... the development of innovative products and services, announced today ... States denied its petition to review decisions ... U.S. Patent No. 6,258,540 (",540 Patent") are not patent ... Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories decision.  ...
Breaking Biology Technology:
(Date:6/22/2016)... American College of Medical Genetics and Genomics was once again ... of the fastest-growing trade shows during the Fastest 50 Awards ... Las Vegas . Winners are ... of the following categories: net square feet of paid exhibit ... 2015 ACMG Annual Meeting was ranked 23 out of 50 ...
(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
Breaking Biology News(10 mins):